Industry Research Reports
Home > Reports > Service & Software > Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 145 Pages
Report ld: 4893130
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Medical Industry accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Site-Directed Mutagenesis Services leading manufacturers including ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, etc., dominate supply; the top five capture approximately % of global revenue, with ACGT leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Site-Directed Mutagenesis Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- ACGT
- Azenta Life Sciences
- Biocompare
- NovoPro Bioscience Inc.
- Charles River
- NZYtech
- Thermofisher
- Creatve Biolabs
- Epoch Life Science
- GeneToProtein
- Genewiz
- GenScript
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Synonymous Mutations
- Missense Mutation
- Nonsense Mutation
Segment by Application
- Medical Industry
- Biological Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Gene Site-Directed Mutagenesis Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Gene Site-Directed Mutagenesis Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Synonymous Mutations
1.2.3 Missense Mutation
1.2.4 Nonsense Mutation
1.3 Market Segmentation by Application
1.3.1 Global Gene Site-Directed Mutagenesis Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Biological Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Site-Directed Mutagenesis Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Site-Directed Mutagenesis Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Site-Directed Mutagenesis Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Site-Directed Mutagenesis Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Synonymous Mutations Market Size by Players
3.3.2 Missense Mutation Market Size by Players
3.3.3 Nonsense Mutation Market Size by Players
3.4 Global Gene Site-Directed Mutagenesis Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Site-Directed Mutagenesis Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Site-Directed Mutagenesis Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
6.4 North America Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Site-Directed Mutagenesis Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
7.4 Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Site-Directed Mutagenesis Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
9.4 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Site-Directed Mutagenesis Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 ACGT
11.1.1 ACGT Corporation Information
11.1.2 ACGT Business Overview
11.1.3 ACGT Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.1.4 ACGT Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.1.5 ACGT Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.1.6 ACGT Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.1.7 ACGT Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.1.8 ACGT Gene Site-Directed Mutagenesis Services SWOT Analysis
11.1.9 ACGT Recent Developments
11.2 Azenta Life Sciences
11.2.1 Azenta Life Sciences Corporation Information
11.2.2 Azenta Life Sciences Business Overview
11.2.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.2.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.2.5 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.2.6 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.2.7 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.2.8 Azenta Life Sciences Gene Site-Directed Mutagenesis Services SWOT Analysis
11.2.9 Azenta Life Sciences Recent Developments
11.3 Biocompare
11.3.1 Biocompare Corporation Information
11.3.2 Biocompare Business Overview
11.3.3 Biocompare Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.3.4 Biocompare Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.3.5 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.3.6 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.3.7 Biocompare Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.3.8 Biocompare Gene Site-Directed Mutagenesis Services SWOT Analysis
11.3.9 Biocompare Recent Developments
11.4 NovoPro Bioscience Inc.
11.4.1 NovoPro Bioscience Inc. Corporation Information
11.4.2 NovoPro Bioscience Inc. Business Overview
11.4.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.4.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.4.5 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.4.6 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.4.7 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.4.8 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services SWOT Analysis
11.4.9 NovoPro Bioscience Inc. Recent Developments
11.5 Charles River
11.5.1 Charles River Corporation Information
11.5.2 Charles River Business Overview
11.5.3 Charles River Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.5.4 Charles River Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.5.5 Charles River Gene Site-Directed Mutagenesis Services Revenue by Product in 2024
11.5.6 Charles River Gene Site-Directed Mutagenesis Services Revenue by Application in 2024
11.5.7 Charles River Gene Site-Directed Mutagenesis Services Revenue by Geographic Area in 2024
11.5.8 Charles River Gene Site-Directed Mutagenesis Services SWOT Analysis
11.5.9 Charles River Recent Developments
11.6 NZYtech
11.6.1 NZYtech Corporation Information
11.6.2 NZYtech Business Overview
11.6.3 NZYtech Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.6.4 NZYtech Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.6.5 NZYtech Recent Developments
11.7 Thermofisher
11.7.1 Thermofisher Corporation Information
11.7.2 Thermofisher Business Overview
11.7.3 Thermofisher Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.7.4 Thermofisher Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.7.5 Thermofisher Recent Developments
11.8 Creatve Biolabs
11.8.1 Creatve Biolabs Corporation Information
11.8.2 Creatve Biolabs Business Overview
11.8.3 Creatve Biolabs Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.8.4 Creatve Biolabs Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.8.5 Creatve Biolabs Recent Developments
11.9 Epoch Life Science
11.9.1 Epoch Life Science Corporation Information
11.9.2 Epoch Life Science Business Overview
11.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.9.5 Epoch Life Science Recent Developments
11.10 GeneToProtein
11.10.1 GeneToProtein Corporation Information
11.10.2 GeneToProtein Business Overview
11.10.3 GeneToProtein Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.10.4 GeneToProtein Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Genewiz
11.11.1 Genewiz Corporation Information
11.11.2 Genewiz Business Overview
11.11.3 Genewiz Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.11.4 Genewiz Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.11.5 Genewiz Recent Developments
11.12 GenScript
11.12.1 GenScript Corporation Information
11.12.2 GenScript Business Overview
11.12.3 GenScript Gene Site-Directed Mutagenesis Services Product Features and Attributes
11.12.4 GenScript Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (2020-2025)
11.12.5 GenScript Recent Developments
12 Gene Site-Directed Mutagenesis ServicesIndustry Chain Analysis
12.1 Gene Site-Directed Mutagenesis Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Site-Directed Mutagenesis Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Site-Directed Mutagenesis Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gene Site-Directed Mutagenesis Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Site-Directed Mutagenesis Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Gene Site-Directed Mutagenesis Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Gene Site-Directed Mutagenesis Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2024)
Table 11. Global Gene Site-Directed Mutagenesis Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Gene Site-Directed Mutagenesis Services Companies Headquarters
Table 13. Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Gene Site-Directed Mutagenesis Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Gene Site-Directed Mutagenesis Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Gene Site-Directed Mutagenesis Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Gene Site-Directed Mutagenesis Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Gene Site-Directed Mutagenesis Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
Table 25. North America Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
Table 27. Europe Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Gene Site-Directed Mutagenesis Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Gene Site-Directed Mutagenesis Services Investment Opportunities and Key Challenges
Table 31. Central and South America Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Gene Site-Directed Mutagenesis Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. ACGT Corporation Information
Table 35. ACGT Description and Major Businesses
Table 36. ACGT Product Features and Attributes
Table 37. ACGT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. ACGT Revenue Proportion by Product in 2024
Table 39. ACGT Revenue Proportion by Application in 2024
Table 40. ACGT Revenue Proportion by Geographic Area in 2024
Table 41. ACGT Gene Site-Directed Mutagenesis Services SWOT Analysis
Table 42. ACGT Recent Developments
Table 43. Azenta Life Sciences Corporation Information
Table 44. Azenta Life Sciences Description and Major Businesses
Table 45. Azenta Life Sciences Product Features and Attributes
Table 46. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Azenta Life Sciences Revenue Proportion by Product in 2024
Table 48. Azenta Life Sciences Revenue Proportion by Application in 2024
Table 49. Azenta Life Sciences Revenue Proportion by Geographic Area in 2024
Table 50. Azenta Life Sciences Gene Site-Directed Mutagenesis Services SWOT Analysis
Table 51. Azenta Life Sciences Recent Developments
Table 52. Biocompare Corporation Information
Table 53. Biocompare Description and Major Businesses
Table 54. Biocompare Product Features and Attributes
Table 55. Biocompare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Biocompare Revenue Proportion by Product in 2024
Table 57. Biocompare Revenue Proportion by Application in 2024
Table 58. Biocompare Revenue Proportion by Geographic Area in 2024
Table 59. Biocompare Gene Site-Directed Mutagenesis Services SWOT Analysis
Table 60. Biocompare Recent Developments
Table 61. NovoPro Bioscience Inc. Corporation Information
Table 62. NovoPro Bioscience Inc. Description and Major Businesses
Table 63. NovoPro Bioscience Inc. Product Features and Attributes
Table 64. NovoPro Bioscience Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. NovoPro Bioscience Inc. Revenue Proportion by Product in 2024
Table 66. NovoPro Bioscience Inc. Revenue Proportion by Application in 2024
Table 67. NovoPro Bioscience Inc. Revenue Proportion by Geographic Area in 2024
Table 68. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services SWOT Analysis
Table 69. NovoPro Bioscience Inc. Recent Developments
Table 70. Charles River Corporation Information
Table 71. Charles River Description and Major Businesses
Table 72. Charles River Product Features and Attributes
Table 73. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Charles River Revenue Proportion by Product in 2024
Table 75. Charles River Revenue Proportion by Application in 2024
Table 76. Charles River Revenue Proportion by Geographic Area in 2024
Table 77. Charles River Gene Site-Directed Mutagenesis Services SWOT Analysis
Table 78. Charles River Recent Developments
Table 79. NZYtech Corporation Information
Table 80. NZYtech Description and Major Businesses
Table 81. NZYtech Product Features and Attributes
Table 82. NZYtech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. NZYtech Recent Developments
Table 84. Thermofisher Corporation Information
Table 85. Thermofisher Description and Major Businesses
Table 86. Thermofisher Product Features and Attributes
Table 87. Thermofisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Thermofisher Recent Developments
Table 89. Creatve Biolabs Corporation Information
Table 90. Creatve Biolabs Description and Major Businesses
Table 91. Creatve Biolabs Product Features and Attributes
Table 92. Creatve Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Creatve Biolabs Recent Developments
Table 94. Epoch Life Science Corporation Information
Table 95. Epoch Life Science Description and Major Businesses
Table 96. Epoch Life Science Product Features and Attributes
Table 97. Epoch Life Science Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Epoch Life Science Recent Developments
Table 99. GeneToProtein Corporation Information
Table 100. GeneToProtein Description and Major Businesses
Table 101. GeneToProtein Product Features and Attributes
Table 102. GeneToProtein Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GeneToProtein Recent Developments
Table 104. Genewiz Corporation Information
Table 105. Genewiz Description and Major Businesses
Table 106. Genewiz Product Features and Attributes
Table 107. Genewiz Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Genewiz Recent Developments
Table 109. GenScript Corporation Information
Table 110. GenScript Description and Major Businesses
Table 111. GenScript Product Features and Attributes
Table 112. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. GenScript Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Site-Directed Mutagenesis Services Product Picture
Figure 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Synonymous Mutations Product Picture
Figure 4. Missense Mutation Product Picture
Figure 5. Nonsense Mutation Product Picture
Figure 6. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medical Industry
Figure 8. Biological Research
Figure 9. Others
Figure 10. Gene Site-Directed Mutagenesis Services Report Years Considered
Figure 11. Global Gene Site-Directed Mutagenesis Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 13. Global Gene Site-Directed Mutagenesis Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2020-2031)
Figure 15. Global Gene Site-Directed Mutagenesis Services Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Synonymous Mutations Revenue Market Share by Player in 2024
Figure 18. Missense Mutation Revenue Market Share by Player in 2024
Figure 19. Nonsense Mutation Revenue Market Share by Player in 2024
Figure 20. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2020-2031)
Figure 21. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2020-2031)
Figure 22. North America Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
Figure 24. North America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
Figure 31. Europe Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 34. France Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 46. India Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Gene Site-Directed Mutagenesis Services Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
Figure 54. Central and South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Gene Site-Directed Mutagenesis Services Revenue (US$ Million) in 2024
Figure 60. South America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Gene Site-Directed Mutagenesis Services Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Gene Site-Directed Mutagenesis Services Revenue (2020-2025) & (US$ Million)
Figure 66. Gene Site-Directed Mutagenesis Services Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Gene Site-Directed Mutagenesis Services market?
The top companies in the global Gene Site-Directed Mutagenesis Services market are ACGT、Azenta Life Sciences、Biocompare.
Related Reports
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-27
Pages: 138
USD 4900.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gene Site-Directed Mutagenesis Services market size was US$ 187 million in 2025 and is forecast to reach a readjusted size of US$ 269 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 97
USD 4250.00
(Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 120
USD 3950.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2026
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 118
USD 2900.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 102
USD 3950.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2025
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 82
USD 2900.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Insights, Forecast to 2030
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-05-27
Pages: 143
USD 4900.00
(Single User License)
Global and United States Gene Site-Directed Mutagenesis Services Market Report & Forecast 2024-2030
The global Gene Site-Directed Mutagenesis Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-05-21
Pages: 107
USD 4350.00
(Single User License)
Gene Site-Directed Mutagenesis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-05-21
Pages: 114
USD 3950.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-27
Pages: 138
USD 4900.00 (Single User License)Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Gene Site-Directed Mutagenesis Services market size was US$ 187 million in 2025 and is forecast to reach a readjusted size of US$ 269 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 97
USD 4250.00 (Single User License)Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 120
USD 3950.00 (Single User License)Global Gene Site-Directed Mutagenesis Services Market Research Report 2026
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 118
USD 2900.00 (Single User License)Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
USD 4250.00 (Single User License)Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 102
USD 3950.00 (Single User License)Global Gene Site-Directed Mutagenesis Services Market Research Report 2025
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 82
USD 2900.00 (Single User License)Global Gene Site-Directed Mutagenesis Services Market Insights, Forecast to 2030
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-05-27
Pages: 143
USD 4900.00 (Single User License)Global and United States Gene Site-Directed Mutagenesis Services Market Report & Forecast 2024-2030
The global Gene Site-Directed Mutagenesis Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-05-21
Pages: 107
USD 4350.00 (Single User License)Gene Site-Directed Mutagenesis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-05-21
Pages: 114
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now